Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016; 18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003; 194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307. Podcast Oct 2009 Ethics Talk: Doctors, Patients, and Spirituality Should doctors ask about their patients' religious or spiritual beliefs? Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021; E18-25. doi: 10.1001/amajethics.2021.18. State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015; 17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511. Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117. Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020; 22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033. Pagination First page « First Previous page ‹ Previous … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page Next › Last page Last »
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016; 18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003; 194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307.
Podcast Oct 2009 Ethics Talk: Doctors, Patients, and Spirituality Should doctors ask about their patients' religious or spiritual beliefs?
Case and Commentary Jan 2021 当医生发现其患者被强制绝育时应如何应对? Rebecca Kluchin(理学博士) AMA J Ethics. 2021; E18-25. doi: 10.1001/amajethics.2021.18.
State of the Art and Science Nov 2015 The Challenge of Understanding Health Care Costs and Charges Vineet Arora, MD, MAPP, Christopher Moriates, MD, and Neel Shah, MD, MPP The price transparency movement seeks to make actual medical costs clear to patients and clinicians. AMA J Ethics. 2015; 17(11):1046-1052. doi: 10.1001/journalofethics.2015.17.11.stas1-1511.
Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021; E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021; E117-126. doi: 10.1001/amajethics.2021.117.
Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020; 22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.